The U.S. Food and Drug Administration (FDA) has granted molecular testing company Rhoenix emergency use authorization for a fully automated test to detect the presence of the novel coronavirus from respiratory samples.
The Rheonix COVID-19 MDx assay provides same-day results for COVID-19 testing, according to the company. The automated workflow doesn't need the assistance of a technician and can be done on-site at distributed locations.
The assay is designed for small- and medium-throughput laboratories and is compatible with the company's Encompass MDx workstation. Rheonix said that it has begun shipping both the workstation and test kits to hospital laboratories.
